Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Reneo Pharmaceuticals (RPHM)

Reneo Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPHM
DateTimeSourceHeadlineSymbolCompany
13/05/202414:38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202414:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202412:35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202412:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
28/03/202411:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
25/03/202411:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
23/02/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
05/02/202421:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202314:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202314:05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
22/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202322:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202321:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202312:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
02/11/202311:50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
30/10/202320:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
25/10/202312:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202312:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
06/10/202313:30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
29/08/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
29/08/202312:35GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
28/08/202322:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202312:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
30/06/202313:25GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics ForumNASDAQ:RPHMReneo Pharmaceuticals Inc
26/06/202313:25GlobeNewswire Inc.Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® IndicesNASDAQ:RPHMReneo Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RPHM

Your Recent History

Delayed Upgrade Clock